Search company, investor...
CyberX company logo

CyberX

cyberx.com

Founded Year

2016

About CyberX

CyberX is committed to building the financial infrastructure for digital currency asset based on the blockchain technology. By utilizing the latest advancements in blockchain, mathematical modeling, deep learning, financial engineering, and data mining, CyberX team is creating a platform to provide a full range of financial services to token issuers, institutional investors/token funds, exchanges, and high net worth clients.

Headquarters Location

chaoyang

Beijing, Beijing, 100020,

China

Missing: CyberX's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: CyberX's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing CyberX

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned CyberX in 2 CB Insights research briefs, most recently on Mar 11, 2021.

CyberX Patents

CyberX has filed 1 patent.

The 3 most popular patent topics include:

  • Analog circuits
  • Computer network security
  • Computer security
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/2/2018

6/9/2020

Network protocols, Cyberwarfare, Computer security, Computer network security, Cyberattacks

Grant

Application Date

7/2/2018

Grant Date

6/9/2020

Title

Related Topics

Network protocols, Cyberwarfare, Computer security, Computer network security, Cyberattacks

Status

Grant

Latest CyberX News

Absci to Participate in the SVB Securities CybeRx: Big Data, A.I. & Machine Learning in Healthcare Event

Jul 21, 2022

& Machine Learning in Healthcare Event 07/21/2022 | 07:02am EDT Message : *Required fields VANCOUVER, Wash. and NEW YORK, July 21, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the upcoming SVB Securities CybeRx: Big Data, A.I. Absci, as a leader in large molecule AI drug discovery, is scheduled to participate in the Drug R&D and Development panel on Wednesday, July 27th at 6:00 a.m. Pacific Time (9:00 a.m. Eastern Time). To virtually attend this live event, please contact your SVB Securities representative with interest. About Absci Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. We built our Integrated Drug Creation™ Platform to identify novel drug targets, discover optimal biotherapeutic candidates, and generate the cell lines to manufacture them in a single efficient process. Biotech and pharma innovators partner with us to create the next generation of protein-based drugs, including Bionic Proteins™ containing nonstandard amino acids, and other novel drug designs that may be impossible to make with other technologies. Our goal is to enable the development of better medicines by Translating Ideas into Drugs™. For more information visit www.absci.com  and follow us on social media: Twitter:  @Abscibio , LinkedIn:  @absci , and subscribe to our Absci YouTube channel . Availability of Other Information about Absci Investors and others should note that we routinely communicate with investors and the public using our website (www.absci.com) and our investor relations website ( investors.absci.com ), including without limitation, through the posting of investor presentations, SEC filings, press releases, public conference calls and webcasts on these websites. The information that we post on these websites could be deemed to be material information. As a result, investors, the media, and others interested in Absci are encouraged to review this information on a regular basis. The contents of our website, or any other website that may be accessed from our website, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended. Absci Investor Contact

CyberX Frequently Asked Questions (FAQ)

  • When was CyberX founded?

    CyberX was founded in 2016.

  • Where is CyberX's headquarters?

    CyberX's headquarters is located at Beijing.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.